Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MWE | Ann: Annual Report for the year ended 30 June 2024 | 25/09/24 | 0 | 50 | |||
|
|||||||
MWE | Ann: Marlborough Wine Estates Announces FY24 Results | 29/08/24 | 0 | 56 | |||
|
|||||||
MWE | Ann: 2024 Leadership Update | 05/04/24 | 0 | 117 | |||
|
|||||||
MWE | Ann: 2024 Harvest Update | 05/04/24 | 0 | 114 | |||
|
|||||||
MWE | Ann: Half Year Report and Results Announcement | 28/02/24 | 0 | 91 | |||
|
|||||||
MWE | Ann: Annual Meeting of Shareholders - Results | 12/12/23 | 0 | 91 | |||
|
|||||||
MWE | Ann: Annual Meeting of Shareholders - Presentation | 12/12/23 | 0 | 101 | |||
|
|||||||
MWE | Ann: Notice of Annual Meeting of Shareholders | 07/11/23 | 0 | 109 | |||
|
See All Discussions